107.90
-0.60
(-0.55%)
At close: January 31 at 9:34:02 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-242,150.00
-436,847.00
-502,277.00
-298,653.00
387,035.00
Investing Cash Flow
-2,441.00
274,040.00
-149,541.00
-225,860.00
-434,249.00
Financing Cash Flow
278,880.00
119,225.00
561,810.00
50,716.00
617,759.00
End Cash Position
99,957.00
81,524.00
124,904.00
215,119.00
689,804.00
Income Tax Paid Supplemental Data
--
--
6,505.00
694.00
778.00
Interest Paid Supplemental Data
69,067.00
38,467.00
9,814.00
--
--
Capital Expenditure
-8,371.00
-16,062.00
-8,919.00
-261,241.00
-3,159.00
Issuance of Capital Stock
--
--
--
--
582,494.00
Issuance of Debt
146,938.00
97,933.00
137,786.00
--
--
Free Cash Flow
-250,521.00
-452,909.00
-511,196.00
-559,894.00
383,876.00
12/31/2020 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6YG.MU Immunocore Holdings plc
31.40
+2.61%
LT4.F Liquidia Corporation
13.76
+1.33%
63E.MU Onward Medical NV
6.34
-6.49%
ASEP.CN ASEP Medical Holdings Inc.
0.0650
-13.33%
63E.F Onward Medical N.V.
6.50
-2.11%
5CV.F CureVac N.V.
3.6520
-1.78%
ONWD.BR Onward Medical N.V.
6.36
+0.95%
SANN.SW Santhera Pharmaceuticals Holding AG
17.12
+4.39%
LQDA Liquidia Corporation
14.23
-1.25%
HOTH Hoth Therapeutics, Inc.
1.2600
-1.56%